Skip to main content
JNJJohnson & JohnsonHold5.3·$240.88
JNJ · Decision

Should you buy Johnson & Johnson (JNJ)?

Updated

A high-quality healthcare franchise with strong margins, a wide economic moat, and strong price momentum has already surpassed its near-term resistance target, leaving the risk/reward unfavorable for new exposure; the setup favors holding an existing position while monitoring the dividend sustainability concern and the most recent earnings miss.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
HOLD
Score
5.3/10
Price
$240.88
Entry / Take Profit (TP) / Stop Loss (SL)
/ $238.18 / $230.20

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

The business sustains strong margins (22%), a return on equity of 26%, and a wide economic moat — a combination indicating durable competitive positioning. A Piotroski score of 7 out of 9 confirms broad financial health.

Stable
Quality breakdown
Expectation
Margins remain at or above current levels over the next four quarters as the competitive position is maintained.

CounterFree cash flow converts at only 59% of reported earnings, a concern the quality data explicitly flags; the gap between reported profitability and cash generation means the stated margins may overstate real cash returns, and if FCF conversion continues to lag, the quality franchise story becomes harder to sustain.

The technical configuration shows a golden cross, price trading above all major moving averages, an RSI of 58, and a bullish MACD — collectively consistent with a sustained breakout pattern driven by institutional buying accumulation.

Stable
Engine gate (passed)
Expectation
Price holds above its 200-day moving average and volume accumulation continues over the next 12 months.

CounterThe stock is already trading above its near-term resistance target, and the risk/reward is unfavorable at current levels; momentum that has already run past the target may lose its catalyst and consolidate or retrace as near-term buyers take profits.

The dividend is flagged as a potential yield trap — a situation where a high stated yield may prove difficult to sustain if earnings or cash flows deteriorate, posing a risk to income-focused holders.

Stable
Catalyst breakdown
Expectation
If this risk materializes, the dividend would be reduced or covered less comfortably, weakening the income case for holding.

CounterThe wide economic moat and Piotroski score of 7 out of 9 indicate the underlying franchise has financial durability; if cash conversion improves from 59% of reported earnings, the dividend may prove better-supported than the current yield-trap flag suggests.

▸ Show 1 more pillar

Earnings estimates are trending upward, providing a positive revision tailwind that can sustain the current valuation even as trailing growth remains soft.

Stable
Bull case
Expectation
Consensus EPS estimates continue rising over the next four quarters, validating the upward revision trend.

CounterThe most recent quarter delivered a miss of -5.86%, preceded by an inline result; two consecutive shortfalls against consensus could stall or reverse the estimate revision cycle that the upward trend depends on.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The business sustains strong margins (22%), a return on equity of 26%, and a wide economic moat — a combination indicating durable competitive positioning. A Piotroski score of 7 out of 9 confirms broad financial health.

    Trip ifMargins fall below 15% for 2 consecutive quarters.

  • P2The technical configuration shows a golden cross, price trading above all major moving averages, an RSI of 58, and a bullish MACD — collectively consistent with a sustained breakout pattern driven by institutional buying accumulation.

    Trip ifRSI falls below 40 for 2 consecutive weeks.

  • P3The dividend is flagged as a potential yield trap — a situation where a high stated yield may prove difficult to sustain if earnings or cash flows deteriorate, posing a risk to income-focused holders.

    Trip ifFCF as a percentage of net income rises above 80% for 2 consecutive quarters.

  • P4Earnings estimates are trending upward, providing a positive revision tailwind that can sustain the current valuation even as trailing growth remains soft.

    Trip ifEPS surprise stays below 0% for 2 consecutive quarters.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Johnson & Johnson (JNJ) is HOLD_IF_HOLDING with medium conviction, score 5.3/10 at $240.88. The F-path SELL output reflects an overall score of 5.3 below the 5.4 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -0.47 is supplementary context, not the trigger.

2. What the engine sees

On the bull side: Strong earnings beat streak (3/4); Earnings estimates trending UP; High-quality business. On the bear side: Analyst target reached - limited upside remaining; Near 52-week high (4.3% away); Weak growth. Active engine warnings: V8: Target reached (-3.9% upside), L3:NEWS_MOD=+1: SELL_IF_HOLDING → HOLD_IF_HOLDING, V9 Gate Failed: ASYMMETRY:-0.5=NEGATIVE.

3. Entry, target, and stop

The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around with a technical stop near $230.20 for existing positions. Asymmetric R:R is -0.27, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

4. What would change the verdict

HOLD flips toward BUY_WAIT if reward-to-risk (NEGATIVE) clears AND a co-confirming gate triggers. HOLD flips toward SELL if any of the currently-passing gates drop below threshold OR three or more dimensions fall below 4 simultaneously.

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates JNJ — 10-dimension breakdown →

Bull case

  • Strong earnings beat streak (3/4)
  • Earnings estimates trending UP
  • High-quality business

Bear case

  • Analyst target reached - limited upside remaining
  • Near 52-week high (4.3% away)
  • Weak growth
Home Stocks JNJ Buy or sell?